Literature DB >> 29545626

Complex regional pain syndrome - phenotypic characteristics and potential biomarkers.

Frank Birklein1, Seena K Ajit2, Andreas Goebel3,4, Roberto S G M Perez5, Claudia Sommer6.   

Abstract

Complex regional pain syndrome (CRPS) is a pain condition that usually affects a single limb, often following an injury. The underlying pathophysiology seems to be complex and probably varies between patients. Clinical diagnosis is based on internationally agreed-upon criteria, which consider the reported symptoms, presence of signs and exclusion of alternative causes. Research into CRPS biomarkers to support patient stratification and improve diagnostic certainty is an important scientific focus, and recent progress in this area provides an opportunity for an up-to-date topical review of measurable disease-predictive, diagnostic and prognostic parameters. Clinical and biochemical attributes of CRPS that may aid diagnosis and determination of appropriate treatment are delineated. Findings that predict the development of CRPS and support the diagnosis include trauma-related factors, neurocognitive peculiarities, psychological markers, and local and systemic changes that indicate activation of the immune system. Analysis of signatures of non-coding microRNAs that could predict the treatment response represents a new line of research. Results from the past 5 years of CRPS research indicate that a single marker for CRPS will probably never be found; however, a range of biomarkers might assist in clinical diagnosis and guide prognosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29545626      PMCID: PMC6534418          DOI: 10.1038/nrneurol.2018.20

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  70 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Do psychological factors influence recovery from complex regional pain syndrome type 1? A prospective study.

Authors:  Debbie J Bean; Malcolm H Johnson; Wolfgang Heiss-Dunlop; Arier C Lee; Robert R Kydd
Journal:  Pain       Date:  2015-11       Impact factor: 6.961

4.  Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome.

Authors:  Sabrina R Douglas; Botros B Shenoda; Rehman A Qureshi; Ahmet Sacan; Guillermo M Alexander; Marielle Perreault; James E Barrett; Enrique Aradillas-Lopez; Robert J Schwartzman; Seena K Ajit
Journal:  J Pain       Date:  2015-06-11       Impact factor: 5.820

5.  Pain and other symptoms of CRPS can be increased by ambiguous visual stimuli--an exploratory study.

Authors:  Jane Hall; Simon Harrison; Helen Cohen; Candida S McCabe; N Harris; David R Blake
Journal:  Eur J Pain       Date:  2010-06-08       Impact factor: 3.931

6.  Analysis of Common Single Nucleotide Polymorphisms in Complex Regional Pain Syndrome: Genome Wide Association Study Approach and Pooled DNA Strategy.

Authors:  Piotr K Janicki; Guillermo M Alexander; Jill Eckert; Marek Postula; Robert J Schwartzman
Journal:  Pain Med       Date:  2016-06-10       Impact factor: 3.750

7.  A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome.

Authors:  Valéria Tékus; Zsófia Hajna; Éva Borbély; Adrienn Markovics; Teréz Bagoly; János Szolcsányi; Victoria Thompson; Ágnes Kemény; Zsuzsanna Helyes; Andreas Goebel
Journal:  Pain       Date:  2013-10-18       Impact factor: 6.961

8.  Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome.

Authors:  R Norman Harden; Stephen Bruehl; Roberto S G M Perez; Frank Birklein; Johan Marinus; Christian Maihofner; Timothy Lubenow; Asokumar Buvanendran; Sean Mackey; Joseph Graciosa; Mila Mogilevski; Christopher Ramsden; Melissa Chont; Jean-Jacques Vatine
Journal:  Pain       Date:  2010-05-20       Impact factor: 6.961

9.  Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939.

Authors:  Marguerite K McDonald; Sujay Ramanathan; Andrew Touati; Yiqian Zhou; Rushi U Thanawala; Guillermo M Alexander; Ahmet Sacan; Seena K Ajit
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

10.  Genome-wide expression profiling of complex regional pain syndrome.

Authors:  Eun-Heui Jin; Enji Zhang; Youngkwon Ko; Woo Seog Sim; Dong Eon Moon; Keon Jung Yoon; Jang Hee Hong; Won Hyung Lee
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more
  34 in total

1.  [Exergames-a new treatment option for CRPS?]

Authors:  Eduard Kraft; Shahnaz Christina Azad
Journal:  Schmerz       Date:  2020-04       Impact factor: 1.107

2.  Skin biomarkers associated with complex regional pain syndrome (CRPS) Type I: a systematic review.

Authors:  Diana Andronic; Octavian Andronic; Astrid Juengel; Martin C Berli; Oliver Distler; Florian Brunner
Journal:  Rheumatol Int       Date:  2022-01-08       Impact factor: 2.631

3.  Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition.

Authors:  R Norman Harden; Candida S McCabe; Andreas Goebel; Michael Massey; Tolga Suvar; Sharon Grieve; Stephen Bruehl
Journal:  Pain Med       Date:  2022-06-10       Impact factor: 3.637

4.  Atypical dermatologic manifestations in complex regional pain syndrome: a case report.

Authors:  Brendan Langford; Thomas P Pittelkow; Arnoley S Abcejo
Journal:  J Med Case Rep       Date:  2022-06-27

Review 5.  Complex regional pain syndrome: a narrative review for the practising clinician.

Authors:  H Shim; J Rose; S Halle; P Shekane
Journal:  Br J Anaesth       Date:  2019-05-02       Impact factor: 9.166

6.  Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Authors:  Zsuzsanna Helyes; Valéria Tékus; Nikolett Szentes; Krisztina Pohóczky; Bálint Botz; Tamás Kiss; Ágnes Kemény; Zsuzsanna Környei; Krisztina Tóth; Nikolett Lénárt; Hajnalka Ábrahám; Emmanuel Pinteaux; Sheila Francis; Serena Sensi; Ádám Dénes; Andreas Goebel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

7.  Complex regional pain syndrome patient immunoglobulin M has pronociceptive effects in the skin and spinal cord of tibia fracture mice.

Authors:  Tian-Zhi Guo; Tzuping Wei; Maral Tajerian; J David Clark; Frank Birklein; Andreas Goebel; Wen-Wu Li; Peyman Sahbaie; Fabiola L Escolano; Myriam Herrnberger; Heidrum H Kramer; Wade S Kingery
Journal:  Pain       Date:  2020-04       Impact factor: 7.926

Review 8.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

Review 9.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

10.  Hsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome.

Authors:  Richa Pande; Ayush Parikh; Botros Shenoda; Sujay Ramanathan; Guillermo M Alexander; Robert J Schwartzman; Seena K Ajit
Journal:  Biomed Pharmacother       Date:  2021-05-29       Impact factor: 7.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.